Avantax Planning Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-2,020
Closed -$45K 241
2018
Q1
$45K Buy
+2,020
New +$45K ﹤0.01% 548